SIADH and hyponatraemia: foreword. - Wikidata - awgldk - TriplyDB

SIADH and hyponatraemia: foreword.

SIADH and hyponatraemia: foreword.

http://www.wikidata.org/entity/Q42013491

about

Vaptans: A new option in the management of hyponatremia.Symptomatic hyponatremia during glomerular filtration rate testing.

P2860

Q39400678-79053894-0520-48E9-8CE1-586A75FAA01B Q40328246-F2908C4B-7F4D-4EA4-BAAE-4D0D659F08DC

P2860

SIADH and hyponatraemia: foreword.

http://www.wikidata.org/entity/Q42013491

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

SIADH and hyponatraemia: foreword.

@en

SIADH and hyponatraemia: foreword.

@nl

type

label

SIADH and hyponatraemia: foreword.

@en

SIADH and hyponatraemia: foreword.

@nl

prefLabel

SIADH and hyponatraemia: foreword.

@en

SIADH and hyponatraemia: foreword.

@nl

P1433

Q42013491-3145985C-5BEF-42E0-AC76-583267635B90

P1476

Q42013491-08F0718E-3C52-486C-BA31-A6A4F41D7BA7

P2093

Q42013491-B3C36184-A2F8-4CFD-98FF-F27430C031BB

Q42013491-DDEF0F1E-6EB8-4AEA-BEC7-91B1EF011DE5

P2860

Q42013491-2180EE02-17C5-478E-9F72-72A969236994

Q42013491-37B5C3D6-7D9F-4196-837E-1D39F843F7A1

Q42013491-3F4C0A0E-0A05-4F7E-B76D-435A7D0C50C2

Q42013491-44DFED3E-8B97-4143-87E4-B70C7EFFAE70

Q42013491-5282BF71-E56F-48ED-8512-ECA0D8FA35FF

Q42013491-59AEE2F5-1F19-413E-A6B4-E7800DA16174

Q42013491-5A850FB2-5C96-46F6-BF3C-39E078EDD75D

Q42013491-685F6E8B-AF01-4AA3-8DDD-D98CDA7563FF

Q42013491-832B95E3-4C82-49EC-95CD-64E41C6CBB5D

Q42013491-A4FB675C-A2F6-47BF-836E-C9DBECC8F5F9

P304

Q42013491-FCB4E0F1-C492-4D7C-A4B9-FCACD06F6061

P31

Q42013491-30FBE173-3E6F-452A-AEC2-11AE78298CAE

P356

Q42013491-5D2852B9-43B3-4C3B-B0A2-D6AD4DB7B0AD

P433

Q42013491-F97EC3F7-74A1-4853-B45E-47A6EB69B8FD

P478

Q42013491-C419879D-0D9A-42BD-8ABC-CE8DC99E222D

P577

Q42013491-6E8D44A5-2971-4DF9-BEBF-9FE7351D3789

P5875

Q42013491-2DFC0D6A-BD5E-4899-92FC-61AB69328646

P698

Q42013491-A0EF985A-EFC1-4EE1-965F-673AB4880F55

P932

Q42013491-58A9B6C5-B892-4F13-B3BC-DEF2A0E9B26A

P356

P1433

P1476

SIADH and hyponatraemia: foreword.

@en

P2093

Anu Trehan

http://www.w3.org/2001/XMLSchema#string

Donal O'Donoghue

http://www.w3.org/2001/XMLSchema#string

P2860

Current and future treatment options in SIADH

Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial

Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial

Hyponatremia: evaluating the correction factor for hyperglycemia.

Is asymptomatic hyponatremia really asymptomatic?

Incidence and prevalence of hyponatremia.

Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia.

Clinical practice. The syndrome of inappropriate antidiuresis.

Hyponatremia treatment guidelines 2007: expert panel recommendations.

Cost of illness of hyponatremia in the United States.

P304

iii1-iii4

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NDTPLUS/SFP152

http://www.w3.org/2001/XMLSchema#string

P433

Suppl_3

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2009-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38060121

http://www.w3.org/2001/XMLSchema#string

P698

19881931

http://www.w3.org/2001/XMLSchema#string

P932

2762825

http://www.w3.org/2001/XMLSchema#string